TY - JOUR
T1 - Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome
T2 - a machine learning analysis
AU - Shimomura, Yoshimitsu
AU - Komukai, Sho
AU - Kitamura, Tetsuhisa
AU - Sobue, Tomotaka
AU - Kurosawa, Shuhei
AU - Doki, Noriko
AU - Katayama, Yuta
AU - Ozawa, Yukiyasu
AU - Matsuoka, Ken ichi
AU - Tanaka, Takashi
AU - Kako, Shinichi
AU - Sawa, Masashi
AU - Kanda, Yoshinobu
AU - Nakamae, Hirohisa
AU - Nakazawa, Hideyuki
AU - Ueda, Yasunori
AU - Kanda, Junya
AU - Fukuda, Takahiro
AU - Atsuta, Yoshiko
AU - Ishiyama, Ken
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2023/2
Y1 - 2023/2
N2 - A conditioning regimen is an essential prerequisite of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome (MDS). However, the optimal conditioning intensity for a patient may be difficult to establish. This study aimed to identify optimal conditioning intensity (reduced-intensity conditioning regimen [RIC] or myeloablative conditioning regimen [MAC]) for patients with MDS. Overall, 2567 patients with MDS who received their first HCT between 2009 and 2019 were retrospectively analyzed. They were divided into a training cohort and a validation cohort. Using a machine learning-based model, we developed a benefit score for RIC in the training cohort. The validation cohort was divided into a high-score and a low-score group, based on the median benefit score. The endpoint was progression-free survival (PFS). The benefit score for RIC was developed from nine baseline variables in the training cohort. In the validation cohort, the hazard ratios of the PFS in the RIC group compared to the MAC group were 0.65 (95% confidence interval [CI]: 0.48–0.90, P = 0.009) in the high-score group and 1.36 (95% CI: 1.06–1.75, P = 0.017) in the low-score group (P for interaction < 0.001). Machine-learning-based scoring can be useful for the identification of optimal conditioning regimens for patients with MDS.
AB - A conditioning regimen is an essential prerequisite of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome (MDS). However, the optimal conditioning intensity for a patient may be difficult to establish. This study aimed to identify optimal conditioning intensity (reduced-intensity conditioning regimen [RIC] or myeloablative conditioning regimen [MAC]) for patients with MDS. Overall, 2567 patients with MDS who received their first HCT between 2009 and 2019 were retrospectively analyzed. They were divided into a training cohort and a validation cohort. Using a machine learning-based model, we developed a benefit score for RIC in the training cohort. The validation cohort was divided into a high-score and a low-score group, based on the median benefit score. The endpoint was progression-free survival (PFS). The benefit score for RIC was developed from nine baseline variables in the training cohort. In the validation cohort, the hazard ratios of the PFS in the RIC group compared to the MAC group were 0.65 (95% confidence interval [CI]: 0.48–0.90, P = 0.009) in the high-score group and 1.36 (95% CI: 1.06–1.75, P = 0.017) in the low-score group (P for interaction < 0.001). Machine-learning-based scoring can be useful for the identification of optimal conditioning regimens for patients with MDS.
UR - http://www.scopus.com/inward/record.url?scp=85141999551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141999551&partnerID=8YFLogxK
U2 - 10.1038/s41409-022-01871-8
DO - 10.1038/s41409-022-01871-8
M3 - Article
C2 - 36376472
AN - SCOPUS:85141999551
SN - 0268-3369
VL - 58
SP - 186
EP - 194
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 2
ER -